This topic contains a solution. Click here to go to the answer

Author Question: Which of the following may reduce the likelihood of a patient developing taste fatigue with a ... (Read 20 times)

sc00by25

  • Hero Member
  • *****
  • Posts: 596
Which of the following may reduce the likelihood of a patient developing taste fatigue with a commercial supplement?
 a. Provide the supplement with all meals.
  b. Inform the patient that she is getting billed with the supplement so she might as well drink it.
  c. Switch to a different supplement.
  d. Develop a rotation for snacks and supplements with the patient.

Question 2

Which situation must be considered when making a decision to start parenteral nutrition?
 a. The length of time nutrition support is needed
  b. The patient's BMI
 c. The patient's need for amino acids in solution
  d. The physician's ability to obtain an order
 e. The need for an automated compounder



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

prumorgan

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

d

Answer to Question 2

a



sc00by25

  • Hero Member
  • *****
  • Posts: 596
Both answers were spot on, thank you once again



prumorgan

  • Sr. Member
  • ****
  • Posts: 326

 

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library